Motoneurone Disease Stroke Peripheral Neuropathy Multiple Sclerosis Lennox-Gastaut Eye Diseases
Drug Platform Discovery Pharmacokinetics Pharmacodynamic Publications
Our Mission Directors
Press Releases


Our Mission StatementDNA

  • To create and deliver a human therapeutic with groundbreaking neurological disease abrogating effects
  • To develop and produce, to the highest standards, a therapeutic for end-users (patients) that combines safety, best practice and outstanding effectiveness
  • To initiate a major international knowledge gain in the scientific field of cellular / neuronal regeneration
  • To complement the New Zealand government’s approach of state of the art technology-based idea transfer to the New Zealand biotech industry to support a knowledge-based economy
  • To provide a milestone for New Zealand’s quest to enter the world stage regarding the implementation of drug development strategies

Go To:

Contact Us About Us Research Target Diseases Investors